Bio-inspired chemometric methods for simultaneous UV spectrophotometric determination of molnupiravir, nirmatrelvir, and favipiravir in pharmaceutical formulations and environmental samples. [PDF]
Sci RepAbdelzaher AM, Al Kamaly O, Rahman MAA.
europepmc +1 more source
Time to anti-cancer treatment resumption after SARS-CoV-2 infection in patients with active haematological diseases undergoing combined antiviral treatments. [PDF]
J Antimicrob ChemotherMatteini E +15 more
europepmc +1 more source
SARS-CoV-2 Infection and Antiviral Strategies: Advances and Limitations. [PDF]
VirusesSoares VC, Moreira IBG, Dias SSG.
europepmc +1 more source
Novel Competitive, Nonpeptidic, SARS-CoV‑2 M<sup>pro</sup> Inhibitors with Improved Solubility. [PDF]
ACS Med Chem LettSahin Z +7 more
europepmc +1 more source
Real-world effectiveness and safety of oral Azvudine versus Paxlovid for COVID-19 in patients with kidney disease: a multicenter, retrospective, cohort study. [PDF]
BMC Infect DisRao B +14 more
europepmc +1 more source
The unprecedented Paxlovid journey from milligrams to millions of patient doses during the Covid-19 pandemic. [PDF]
Commun Med (Lond)Yu W +11 more
europepmc +1 more source
Risk Factors for Seeking Medical Care Following Nirmatrelvir-Ritonavir (Paxlovid) Treatment for COVID-19: "Symptom Rebound". [PDF]
VirusesBhargava A +3 more
europepmc +1 more source
Genetic Predictors of Paxlovid Treatment Response: The Role of IFNAR2, OAS1, OAS3, and ACE2 in COVID-19 Clinical Course. [PDF]
J Pers MedBuchynskyi M +5 more
europepmc +1 more source